Document text
Principal Investigator: Rafi Ahmed
Organization: EMORY UNIVERSITY
Fiscal Year: 2024
Award: $396,354
Funding agency: National Institute of Allergy and Infectious Diseases
ABSTRACT
Immunological memory is a fundamental feature of the adaptive immune system. However emerging evidence
demonstrates that the innate immune system can also display a form of adaptive, memory-like behavior, a
phenomenon termed “trained immunity.” Recently using single cell ATAC-seq we demonstrated that
immunization of humans with the AS03-adjuvanted H5N1 pandemic influenza vaccine stimulates persistent
epigenomic imprints in blood myeloid cells, that results in a heightened resistance to infection with
heterologous viruses Zika and Dengue viruses, and reduced chromatin accessibility of loci targeted by
the AP-1 transcription factors leading to reduced capacity to produce pro-inflammatory cytokines. These
observations raise several key questions: 1) Do SARS-CoV-2 infection and vaccination stimulate functionally
distinct long-term epigenetic innate reprogramming? 2) Is epigenetic imprinting of innate immunity “tunable,” by
sequential infections or vaccinations? 3) What is the impact of SARS-CoV-2 vaccination or infection on
epigenetic imprinting of innate immunity in tissues? 4) What are the mechanisms of innate memory induced by
vaccination and their effects on protection against heterologous pathogens?
These questions will be addressed in the following specific aims:
Aim 1. Perform a longitudinal analysis of the evolution of the innate response following sequential
rounds of SARS-CoV-2 infection or vaccination. We will perform a longitudinal analysis of the single cell
transcriptional and epigenetic landscape of the innate immune system using banked PBMCs collected before,
during and after infection from a COVID-19 cohort of healthcare workers and followed longitudinally from the
beginning of the pandemic, through every infection and vaccination.
Aim 2. Define the transcriptional and epigenetic landscape and function of myeloid cells in tissues. Most
studies have only examined epigenetic imprinting of innate immunity in the blood, and the effects in tissues
remain unclear. In sub-aim 2a we will assess the transcriptional and epigenomic landscape of myeloid-lineage
cells in human mucosal and lymphoid tissues obtained from organ donors. In sub-aim 2b, we will use banked
samples from completed studies in nonhuman primates to assess the transcriptional and epigenomic landscape
of innate immune cells in various tissues and blood following SARS-CoV-2 infection or vaccination.
Aim 3: To assess the mechanisms of innate memory induced by vaccination and their effects on
protection against heterologous pathogens. In this aim we will use mice to explore the mechanisms
underlying innate memory to vaccination, and its functional consequences on protection against heterologous
infections.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV vaccine><AP-1><AP-1 Enhancer-Binding Protein><AP1><AP1 protein><Activator Protein-1><Adaptive Immune System><Address><Adjuvant><Attenuated Vaccines><BNT 162b2><BNT162b2><Basal Transcription Factor><Basal transcription factor genes><Behavior><Blood><Blood Reticuloendothelial System><Blood monocyte><Body Tissues><Breakbone Fever Virus><COVID-19><COVID-19 infection><COVID-19 vaccination><COVID-19 vaccine><COVID-19 virus><COVID-19 virus infection><COVID19 infection><COVID19 virus><CV-19><Cell Body><Cell Lineage><Cells><Chromatin><CoV-2><CoV2><Coronavirus Infectious Disease 2019><DENV><Dendritic Cells><Dengue Virus><Dengue fever virus><Enhancer-Binding Protein AP1><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Evolution><Exposure to><Frequencies><Gene Transcription><General Transcription Factor Gene><General Transcription Factors><Genes><Genetic Transcription><Grant><H5N1><H5N1 virus><Health Care Providers><Health Personnel><Healthcare Providers><Healthcare worker><Human><IFN><Immune><Immune memory><Immune response><Immunes><Immunity><Immunization><Immunologic Memory><Immunologic Receptors><Immunological Memory><Immunological Receptors><Immunological response><In Vitro><Infection><Inflammatory><Influenza A H5N1><Influenza A Virus, H5N1 Subtype><Influenza Vaccines><Innate Immune System><Innate Immunity><Interferons><KO mice><Knock-out Mice><Knockout Mice><Ligands><Live-attenuated Vaccine><Lymphatic Tissue><Lymphoid Tissue><Marrow monocyte><Memory><Mice><Mice Mammals><Modern Man><Mucosa><Mucosal Tissue><Mucous Membrane><Murine><Mus><Myelogenous><Myeloid><Myeloid Cells><Native Immunity><Natural Immunity><Non-Specific Immunity><Nonspecific Immunity><Null Mouse><Organ Donor><PBMC><Peripheral Blood Mononuclear Cell><Pfizer covid19 vaccine><Pfizer-BioNTech COVID-19 vaccine><Pfizer-BioNTech coronavirus disease 2019 vaccine><Pfizer/BioNTech vaccine><RNA Expression><RNA immunization><RNA vaccination><Receptor Protein><Research Resources><Resistance to infection><Resources><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 infection><SARS-CoV-2 vaccination><SARS-CoV-2 vaccine><SARS-CoV2><SARS-CoV2 infection><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 vaccine><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 vaccination><Severe acute respiratory syndrome coronavirus 2 vaccine><Severe acute respiratory syndrome related corona virus 2><Time><Tissues><Training><Transcription><Transcription Factor AP-1><Transcription Factor Proto-Oncogene><Transcription factor genes><Vaccination><Vaccines><Veiled Cells><Virus><Wuhan coronavirus><ZIKV><Zika Virus><acquired immune system><after COVID-19 infection><after SARS-CoV-2 infection><after SARS-CoV2 infection><after infection by SARS-CoV-2><after severe acute respiratory distress syndrome CoV-2 infection><aged><analyzing longitudinal><anamnestic reaction><avian influenza H5N1><avian influenza H5N1 virus><biological systems><cell type><cohort><coronavirus disease 2019><coronavirus disease 2019 infection><coronavirus disease 2019 vaccination><coronavirus disease 2019 vaccine><coronavirus disease 2019 virus><coronavirus disease-19><coronavirus disease-19 vaccine><coronavirus disease-19 virus><coronavirus infectious disease-19><cytokine><epigenetically><epigenomics><flu vaccine><flu virus pandemic><flu virus vaccine><following COVID-19 infection><following SARS-CoV-2 infection><following SARS-CoV2 infection><following infection by SARS-CoV-2><following severe acute respiratory distress syndrome CoV-2 infection><hCoV19><health care personnel><health care worker><health provider><health workforce><healthcare personnel><host response><immune receptor><immune system response><immunoresponse><imprint><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><infection resistance><influenza virus pandemic><influenza virus vaccine><live vaccine><live vaccines><longitudinal analysis><mRNA immunization><mRNA vaccination><medical personnel><monocyte><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><nCoV2><non-human primate><nonhuman primate><novel><pandemic><pandemic disease><pandemic flu><pandemic influenza><pandemic strain of influenza><pathogen><post SARS-CoV-2 infection><previous COVID-19 infection><previous SARS-CoV-2 infection><previous SARS-CoV2 infection><previous severe acute respiratory distress syndrome CoV-2 infection><prior COVID-19 infection><prior SARS-CoV-2 infection><prior SARS-CoV2 infection><prior severe acute respiratory distress syndrome CoV-2 infection><receptor><response><scATAC sequencing><scATAC-seq><secondary immune response><single cell ATAC-seq><single cell ATAC-sequencing><single cell Assay for Transposase Accessible Chromatin sequencing><single cell analysis><single cell sequencing assay for transposase accessible chromatin><single-cell Assay for Transposase-Accessible Chromatin with sequencing><single-cell assay for transposase-accessible chromatin using sequencing><single-cell assay for transposase-accessible chromatin-seq><transcription factor><treatment provider><vaccinate against COVID-19><vaccinate against SARS-CoV-2><vaccinate against coronavirus disease 2019><vaccinate against severe acute respiratory syndrome coronavirus 2><vaccination against COVID-19><vaccination against SARS-CoV-2><vaccination against Severe acute respiratory syndrome coronavirus 2><vaccination against coronavirus disease 2019><vaccine against 2019-nCov><vaccine against COVID-19><vaccine against SARS-CoV-2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine against flu><vaccine against influenza><vaccine candidates against SARS-CoV-2><vaccine for novel coronavirus><vaccines preventing COVID><vaccines to prevent COVID><zikav>